PatientsVille.com Logo

SUBARACHNOID HAEMORRHAGE and Tikosyn

PatientsVille

SUBARACHNOID HAEMORRHAGE Symptoms and Causes

A stroke is a medical emergency. There are two types - ischemic and hemorrhagic. Hemorrhagic stroke is the less common type. It happens when a blood vessel breaks and bleeds into the brain. Within minutes, brain cells begin to die. Causes include a bleeding aneurysm, an arteriovenous malformation (AVM), or an artery wall that breaks open.

Symptoms of stroke are

  • Sudden numbness or weakness of the face, arm or leg (especially on one side of the body)
  • Sudden confusion, trouble speaking or understanding speech
  • Sudden trouble seeing in one or both eyes
  • Sudden trouble walking, dizziness, loss of balance or coordination
  • Sudden severe headache with no known cause

It is important to treat strokes as quickly as possible. With a hemorrhagic stroke, the first steps are to find the cause of bleeding in the brain and then control it. Surgery may be needed. Post-stroke rehabilitation can help people overcome disabilities caused by stroke damage.

National Institute of Neurological Disorders and Stroke

Check out the latest treatments for SUBARACHNOID HAEMORRHAGE

SUBARACHNOID HAEMORRHAGE treatment research studies

Tikosyn clinical trials, surveys and public health registries


Find Drug Side Effect reports



Tikosyn Side Effects

Atrial Fibrillation (267)
Dizziness (156)
Fatigue (116)
Dyspnoea (110)
Headache (94)
Electrocardiogram Qt Prolonged (86)
Heart Rate Increased (83)
Condition Aggravated (79)
Arrhythmia (74)
Asthenia (68)
Nausea (62)
Chest Pain (61)
Diarrhoea (52)
Palpitations (48)
Feeling Abnormal (48)
Torsade De Pointes (45)
Urinary Tract Infection (40)
Blood Pressure Increased (39)
Cardiac Disorder (35)
Insomnia (34)
Heart Rate Irregular (32)
Pneumonia (31)
Hypertension (31)
Death (30)
Blood Potassium Decreased (30)
Malaise (30)
Ventricular Tachycardia (30)
Pain In Extremity (28)
Weight Decreased (27)
Vision Blurred (26)
Arthralgia (25)
Heart Rate Decreased (25)
Cough (25)
Weight Increased (24)
Anxiety (23)
Nasopharyngitis (22)
Tremor (21)
Hyperhidrosis (21)
Blood Creatinine Increased (20)
Chest Discomfort (20)
Renal Impairment (20)
Fall (20)
Muscle Spasms (19)
Vomiting (19)
Infection (19)
Blood Pressure Decreased (19)
Bronchitis (18)
Cardiac Failure Congestive (18)
Depression (18)
Dysphagia (18)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

SUBARACHNOID HAEMORRHAGE Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Recruiting PVI Using Cryoablation Alone in Paroxysmal AtF Patients Converted From Persistent AF With Dofetilide
Condition: Persistent AF Converted to Paroxysmal AF or Sinus Rhythm
Intervention: Procedure: Ablation
Outcome Measure: Freedom from atrial fibrillation/flutter
2 Recruiting Catheter Ablation for Recently Diagnosed Paroxysmal Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Drug: Antiarrhythmic drug;   Procedure: Catheter ablation
Outcome Measures: Percentage of AF burden;   All-death death
3 Recruiting Comparison of Reverse Remodeling and PVI Versus CFAE and/or Linear Lesions and PVI for Persistent AF
Condition: Persistent Atrial Fibrillation
Intervention: Procedure: Ablation
Outcome Measure: Freedom of atrial fibrillation/flutter
4 Recruiting Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial
Conditions: Atrial Fibrillation;   Arrhythmia
Interventions: Device: Left atrial ablation;   Drug: Rate or Rhythm Control Therapy
Outcome Measures: LA catheter ablation is superior to rate or rhythm control drug therapy for decreasing the incidence of the composite endpoint of total mortality, disabling stroke, serious bleeding, or cardiac arrest in patients warranting therapy for AF.;   LA catheter ablation is superior to rate or rhythm control drug therapy for reducing total mortality;   Total mortality or cardiovascular hospitalization;   Cardiovascular death;   Cardiovascular death or disabling stroke;   Arrhythmic death or cardiac arrest;   Heart failure death;   Freedom from recurrent AF;   Cardiovascular hospitalization;   Medical costs, resource utilization, and cost effectiveness;   Quality of Life;   Composite adverse events;   Left atrial size, morphology and function and its relationship to morbidity and mortality